Patent US4832686A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4832686A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for administering interleukin-2

Assignee: Individual
•
Filing: 1986-06-24
•
Granted: 1989-05-23
•
Expires: 2006-06-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A biocompatible, biodegradable, bioerodible composite polymer matrix comprising interleukin-2 in an appropriate polymer. The polymer may be a polymer or copolymer of lactic acid, lactide, glycolide, glutamic acid, or it may be collagen or albumin. The material contains from 10 2 to 10 8 U IL-2/g of polymer. Also disclosed is a method for making the composite polyer matrix and a method for implanting the material. A soft, malleable controlled-release composite material may be used for intracranial or other implantation and may be shaped or molded to fit the site from which malignant tissue has been removed, opposing the residual tumor, complementing hemostasis, compatible with anatomical structure, and functioning as an implantable immunotherapeutic adjuvant.

Inventors

  • 👤 Mark E. Anderson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:23
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641; A61K9/1647; A61K38/00; A61K38/16; A61K38/17; A61K38/19; A61K38/20; A61K38/2013; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2031; A61K9/204; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5031

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 45 words
A method for administering interleukin-2, comprising the step of intracranially implanting into an area from which a neoplasm has been removed a controlled-release polymer matrix, comprising a biocompatible, bioerodible, hemostatic polylactic acid polymer material and interleukin-2 which material is malleable at the time of implantation.
Claim 2
Independent Claim 45 words
A method for administering interleukin-2, comprising the step of intracranially implanting into an area from which a neoplasm has been removed a controlled-release polymer matrix, comprising a biocompatible, bioerodible, hemostatic polylactic acid polymer material and interleukin-2 which material is malleable at the time of implantation.
Claim 3
Dependent Claim 10 words
The method of claim 1, wherein said neoplasm is glioblastoma.
Claim 4
Dependent Claim 33 words
The method of claim 1, further comprising the step of shaping said polymer material to fit the site from which said neoplasm was removed, thereby restoring the brain to its normal anatomical configuration.
Claim 5
Dependent Claim 14 words
The method of claim 1, wherein said polymer matrix further comprises a chemotherapeutic agent.
Claim 6
Dependent Claim 12 words
The method of claim 4, wherein said chemotherapeutic agent is a nitrosourea.
Claim 7
Dependent Claim 13 words
The method of claim 5, wherein said chemotherapeutic agent is BCNU or methyl-CCNU.
Claim 8
Dependent Claim 16 words
The method of claim 1, wherein said polymer matrix is in the form of a paste.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-05-22 1992-11-21 1993-05-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-05-22 1996-11-21 1997-05-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-05-22 2000-11-21 2001-05-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag